Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05436951 · ClinicalTrials.gov registry record · NA

Night Shift Work, On-shift Napping, and Endothelial Function: A Pilot Study

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT05436951: Completed NA study, sponsored by University of Pittsburgh.

NCT05436951 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05436951, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

Cardiovascular disease (CVD) and CVD risk factors such as high blood pressure (BP) are disproportionately higher among night shift workers, including those who work in public safety and healthcare. The purpose of this pilot study is to assess feasibility of collecting data germane to key indicators of cardiovascular health (i.e., ambulatory blood pressure) repeatedly during a simulated night shift protocol. The primary outcome measure will be the number of participants for which at least 70% of required ambulatory BP measures were collected. A result of at least 10 participants/subjects will be considered feasible.

Primary Outcome

A result of at least 10 participants will be considered feasible

Interventions

  • BEHAVIORAL Brief on-shift nap

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2022-06-28
Est. Completion 2023-03-04
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT05436951 record still lists

NCT05436951 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Brief on-shift nap is the first listed.

NCT05436951 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05436951 about?

NCT05436951 is a clinical study titled "Night Shift Work, On-shift Napping, and Endothelial Function: A Pilot Study". Cardiovascular disease (CVD) and CVD risk factors such as high blood pressure (BP) are disproportionately higher among night shift workers, including those who work in public safety and healthcare. The purpose of this pilot study is to assess feasibility of collecting data germane to key indicators ...

What is the current status of trial NCT05436951?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2022-06-28. Estimated completion is 2023-03-04.

What interventions are being tested in trial NCT05436951?

The interventions under investigation include: Brief on-shift nap (BEHAVIORAL).

Who is sponsoring clinical trial NCT05436951?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05436951's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05436951, the US trial registry maintained by the National Library of Medicine. NCT05436951 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.